Skip to content

Application of esketamine to the quality of early postoperative rehabilitation of hysteroscopic patients

Application of esketamine to the quality of early postoperative rehabilitation of hysteroscopic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093601
Enrollment
Unknown
Registered
2024-12-09
Start date
2023-10-09
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological disease

Interventions

Experimental group:Esketamine is used during induction
Control group:Fentanyl is used during induction

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age :18 ~ 60 years 2.ASAI~II 3.BMI:18.5-23.9kg/m2 4.Indications for hysteroscopic surgery 5.Agree and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1.Combined with severe hypertension, cardiovascular and respiratory diseases 2.She has a history of severe hyperthyroidism 3.Have neurological or mental illness 4.A long history of smoking and alcoholism 5.Have taken or are currently taking opioids and non-steroidal anti-inflammatory drugs 48 hours before surgery 6.Allergic to the investigational drugs esketamine or propofol 7. A history of addiction to opioids, esketamine 8.Uterine or cervical duct congenital malformation, cervical duct stenosis severe 9.Intrauterine adhesions make hysteroscopy difficult to perform 10.Patients who are deemed inappropriate by clinicians to participate in clinical trials

Design outcomes

Primary

MeasureTime frame
QOR-40;

Secondary

MeasureTime frame
Ostoperative rehabilitation index;Anesthetic effect;Systolic pressure;Heart rate;Oxygen saturation;Diastolic pressure;

Countries

China

Contacts

Public ContactLuo Chenfang

The Third Affiliated Hospital of Sun Yat-sen University

15975604518@139.com+86 189 0300 6039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026